Although public awareness of breast cancer is growing, World Health Organization (WHO) experts predict that the number of women hearing that diagnosis could increase significantly in the coming years. Early detection of potentially dangerous lesions remains crucial in improving prognosis – it offers an opportunity to begin effective treatment and improve quality of life. That is what AILIS does best.

Innovative method
It is safe, painless, non-invasive and doesn’t generate ionising radiation – that’s how the AILIS breast exam can be described in a nutshell. This solution was developed by a group of experts: doctors, scientists and programmers, as well as specialists in artificial intelligence and biomedical engineering. The end result of nine years of intensive research and development is the world’s first breast health monitoring system that combines medicine with solutions using AI and new technologies.

During the breast exam, a specially designed device takes 21 thousand measurements in just 4 minutes. It achieves that by utilising the proprietary Parametric Dynamic Imaging method, which is able to detect increased blood flow and metabolic levels and use this data to determine cancer risk. The collected results are then analysed by proprietary artificial intelligence algorithms.

The whole system is brought together in a special app, where the patient will receive information about the results as early as 10 minutes after the exam. However, if AI detects any abnormalities while checking the data, the information will be immediately forwarded to a radiologist who will conduct a video consultation with the patient. The app is expected to include other features, such as a personalised breast health monitoring plan and a module to help with self-examination. A quite novel solution, one that cannot yet be implemented given current diagnostic methods, will be a function for calculating individual breast cancer risk. It will be based on an in-depth medical history – including previous imaging results and information on breast density, genetic burden or BMI.

Overcoming barriers
The new technology is expected to assist the medical system in many fields. It was established primarily to reduce the amount of money spent on health care, and as a response to the problem of the alarmingly increasing number of patients. Importantly, in countries where existing regulations permit, it is possible to conduct the exam fully automatically, without the need for an operator, and consult the results with a doctor only if the system detects worrying changes. Ultimately, the technology is to be available not only in Poland, but also on international markets, including countries with different cultural, religious and social conditions, where there are restrictive norms regarding contact between patients and medical personnel. According to the AILIS team, instead of medical facilities, the breast exams are to be conducted at shopping malls, etc. This will allow women who skip preventive check-ups due to lack of time to check their health during their daily shopping.

The state-of-the-art system is also expected to make it easier to monitor the health of so-called dense breasts – i.e. made up predominantly of glandular tissue. This is because, in their case, mammography screening is less effective and it may be more difficult to detect cancer. AILIS is based on its own breast density algorithm and personalises the results for each patient accordingly.

Getting closer
The start-up can already boast the recognition of specialists in many industries, such as AI, medical technology, and design, as well as a number of awards, including international awards received in the HTN AI and Data Awards 2025 competition. The technology is currently undergoing clinical evaluation. The first stage of this process is a medical experiment conducted in cooperation with the National Institute of Oncology in Krakow. Once the certification process is successfully completed, AILIS aims to launch its first commercial breast diagnostic centre.

Michał Matuszewski
CEO AILIS

We consider prevention to be a priority, as it is for the Dr Irena Eris brand, whose innovative cosmetics are gaining worldwide recognition. AILIS has one goal – to protect women’s health through early detection of breast cancer lesions. Dr Irena Eris cares about women on a day-to-day basis, which is why our joint activities focus on overcoming barriers, especially those related to the fear of self-examination. Together, we want to encourage women to consciously care for their own health.

Joining forces
In 2023, Dr Irena Eris joined the ranks of partners supporting AILIS – since then they have been working together to educate women about prevention and regular breast self-examination.